{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T06:31:34Z","timestamp":1786516294557,"version":"build-2736575974"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Pheochromocytoma can cause various cardiovascular complications, but presenting as acute ST-segment elevation myocardial infarction (STEMI) without coronary artery abnormalities is rare. We report the case of a young patient to highlight the associated diagnostic challenges. A 26-year-old female presented with acute chest pain, ST-segment elevation, and elevated cardiac enzymes. Coronary angiography revealed no stenosis. She developed severe heart failure with blood pressure variability (ranging from 153\/120 mmHg to 60\/40 mmHg). Laboratory results showed elevated catecholamine levels, and imaging identified a 9.7\u00d77.6 cm adrenal mass. Histopathology confirmed pheochromocytoma. This case suggests that pheochromocytoma should be considered in young patients presenting with STEMI and heart failure without coronary lesions, particularly when accompanied by blood pressure variability. It offers a systematic differential diagnosis framework for distinguishing pheochromocytoma crisis from Takotsubo syndrome and acute myocarditis in emergency settings.<\/jats:p>","DOI":"10.3389\/fendo.2026.1868268","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T05:58:44Z","timestamp":1786514324000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case report: pheochromocytoma presenting as acute ST-segment elevation myocardial infarction without coronary artery abnormalities"],"prefix":"10.3389","volume":"17","author":[{"given":"Jingyuan","family":"Yi","sequence":"first","affiliation":[{"name":"General Inpatient Department, West China Health Care Hospital, Sichuan University","place":["Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianfeng","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of Cardiology, West China Hospital, Sichuan University","place":["Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihua","family":"Zhao","sequence":"additional","affiliation":[{"name":"Physical Examination Center, Wang Jiang Hospital, Sichuan University","place":["Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-025-02639-9","article-title":"Global epidemiology of pheochromocytoma: a systematic review and meta-analysis of observational studies","volume":"48","author":"Vitturi","year":"2025","journal-title":"J Endocrinol Invest"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9082435","article-title":"Cardiovascular manifestations and complications of pheochromocytomas and paragangliomas","volume":"9","author":"Y-Hassan","year":"2020","journal-title":"J Clin Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1306294","article-title":"High incidence of cardiovascular complications in pheochromocytoma","volume":"44","author":"Zelinka","year":"2012","journal-title":"Horm Metab Res"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2019-0494","article-title":"Phaeochromocytoma presenting as Takotsubo cardiomyopathy","volume":"20","author":"Kayode","year":"2020","journal-title":"Clin Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-19-0089","article-title":"Myocardial infarction with non-obstructed coronaries \u2013 atypical presentation of pheochromocytoma","volume":"2019","author":"Melson","year":"2019","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ecl.2026.01.007","article-title":"Pheochromocytomas and paragangliomas","volume":"55","author":"Alkaissi","year":"2026","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2025.110439","article-title":"Pheochromocytoma manifested as a surgical emergency","volume":"51","author":"Yiannakopoulou","year":"2025","journal-title":"Eur J Surg Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.14744\/SEMB.2020.18794","article-title":"Pheochromocytoma and paraganglioma: from epidemiology to clinical findings","volume":"54","author":"Aygun","year":"2020","journal-title":"Sisli Etfal Hastan Tip Bul"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-199012000-00027","article-title":"Pheochromocytoma and acute myocardial infarction","volume":"83","author":"Nirgiotis","year":"1990","journal-title":"South Med J"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v9.i15.3752","article-title":"Pheochromocytoma in a 49-year-old woman presenting with acute myocardial infarction: a case report","volume":"9","author":"Wu","year":"2021","journal-title":"World J Clin cases"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.00140","article-title":"ST-segment elevation myocardial infarction related to potential spontaneous coronary thrombosis in pheochromocytoma crisis","volume":"11","author":"Chen","year":"2020","journal-title":"Front Endocrinol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2015-214134","article-title":"Phaeochromocytoma presenting with ST segment elevation myocardial infarction","volume":"2016","author":"Ahmed","year":"2016","journal-title":"BMJ Case Rep"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-010-9319-3","article-title":"Exercise-induced nausea and vomiting: another sign and symptom of pheochromocytoma and paraganglioma","volume":"37","author":"King","year":"2010","journal-title":"Endocrine"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2024-263311","article-title":"Phaeochromocytoma mimicking acute ST-elevation myocardial infarction","volume":"17","author":"Ackfeld","year":"2024","journal-title":"BMJ Case Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s12022-017-9469-4","article-title":"A somatic HIF2\u03b1 mutation-induced multiple and recurrent pheochromocytoma\/paraganglioma with polycythemia: clinical study with literature review","volume":"28","author":"Liu","year":"2017","journal-title":"Endocr Pathol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.03.543","article-title":"Pheochromocytoma is characterized by catecholamine-mediated myocarditis, focal and diffuse myocardial fibrosis, and myocardial dysfunction","volume":"67","author":"Ferreira","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-019-02035-3","article-title":"Pheochromocytoma- and paraganglioma-triggered Takotsubo syndrome","volume":"65","author":"Y-Hassan","year":"2019","journal-title":"Endocrine"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy076","article-title":"International expert consensus document on Takotsubo syndrome (Part I): clinical characteristics, diagnostic criteria, and pathophysiology","volume":"39","author":"Ghadri","year":"2018","journal-title":"Eur Heart J"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002438","article-title":"Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension","volume":"38","author":"Lenders","year":"2020","journal-title":"J Hypertens"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an Endocrine Society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1868268\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T05:58:48Z","timestamp":1786514328000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1868268\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":20,"alternative-id":["10.3389\/fendo.2026.1868268"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1868268","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"article-number":"1868268"}}